Sign In
Buy BNTX
$91.35
-0.90 (-0.98%)
At Close: Aug 04, 2026
100 Billion Reasons to Like This Dominant Healthcare Stock
07:00am, Monday, 06'th Jun 2022
This mega-cap stock will become the first in the pharmaceutical industry to reach a major sales milestone.
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
05:43am, Sunday, 05'th Jun 2022
These were the industry's bestsellers last year, but how long can they stay on top?
7 of the Best Cheap Stocks to Buy for the Second Half of 2022
06:26pm, Wednesday, 25'th May 2022
These are the best cheap stocks to invest in now. They all offer compelling buying opportunities in today's volatile market.
Pfizer & BioNTech COVID Jab Booster Effective in Kids Under 5
10:32am, Tuesday, 24'th May 2022
Pfizer (PFE) and BioNTech (BNTX) state that their three-dose COVID-19 vaccine is 80% effective in children under five years of age.
Pfizer/BioNTech say third vaccine dose is 80% effective against Omicron in kids 5 and younger
10:00am, Monday, 23'rd May 2022
Pfizer Inc (NYSE:PFE) and BioNTech SE say their three-dose Covid-19 vaccine for children ages 6 months to 5 years old was 80% effective at preventing illness during the surge of the Omicron variant. A
Why BioNTech Stock Surged Today
03:43pm, Thursday, 19'th May 2022
An overall market rebound and Tuesday's authorization of boosters for kids likely propelled the stock higher.
FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years
04:05pm, Tuesday, 17'th May 2022
The FDA has authorized a booster shot of Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine for children aged 5 to 11. Kids will be eligible for the booster at least five m
Why BioNTech Stock Jumped Today
03:52pm, Tuesday, 17'th May 2022
5- to 11-year-olds are now eligible to get booster shots of the Comirnaty COVID-19 vaccine.
FDA authorizes a booster dose of BioNTech/Pfizer's vaccine for 5 to 11 year olds
11:08am, Tuesday, 17'th May 2022
The Food and Drug Administration said Tuesday that children between the ages of 5 and 11 years old can get a booster dose of BioNTech SE and Pfizer Inc.'s PFE, +1.28% COVID-19 vaccine. Children in thi
3 Dirt-Cheap Stocks You Can Buy Right Now
07:04am, Saturday, 14'th May 2022
These stocks are inexpensive yet have solid underlying businesses.
Will BioNtech sustain the $140 support level?
04:40pm, Friday, 13'th May 2022
BioNtech SE (NASDAQ: BNTX) is bullish this week, having gained 16.03% to trade at $158. The gains come after the company reported growth in vaccine sales.
Why BioNTech Stock Climbed Today
02:53pm, Monday, 09'th May 2022
Global demand for the vaccine maker's COVID-19 drug remains strong.
BioNTech SE (BNTX) CEO Ugur Sahin on Q1 2022 Results - Earnings Call Transcript
12:57pm, Monday, 09'th May 2022
BioNTech SE (NASDAQ:BNTX ) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Sylke Maas - VP, IR and Business Strategy Ugur Sahin - Co-Founder & CEO Ozlem Tureci - Co-Founde
Why BioNTech Stock Is Rising Today
10:10am, Monday, 09'th May 2022
BioNTech SE (NASDAQ: BNTX) shares are trading higher Monday after the company reported financial results and reaffirmed its 2022 outlook. BioNTech reported first-quarter revenue of 6.37 billion euros
BioNTech Stock Rises After Reiterating Guidance
09:33am, Monday, 09'th May 2022
The shares of BioNTech SE (NASDAQ:BNTX) are inching higher ahead of the open, last seen up 0.8% at $137.20, after the pharma giant reported better-than-expected first-quarter earnings, as well as
